To present the results of a retrospective comparative unicentric institutional study of the incidence of postcataract surgery endophthalmitis before and after the introduction of the European Society of Cataract and Refractive Surgeons (ESCRS) protocol in 2007 in our department.
Methods
This study included 15,689 eyes of patients undergoing cataract surgery between 2005 and 2011. Surgeries were performed by 9 different surgeons. After June 2007, the ESCRS protocol was introduced, and all patients underwent intracameral injection of 1 mg of cefuroxime (10 mg/mL) at the end of cataract surgery. Cefuroxime was prepared prior to surgery in the operating room. All patients were observed between 6 weeks and 3 months after surgery.
Results
Between January 2005 and June 2007, before the introduction of the ESCRS protocol in our department, 2299 patients underwent cataract surgery and there were 6 cases of postoperative endophthalmitis (0.26%). After the introduction of the protocol, 13,390 surgeries were performed and there were no cases of endophthalmitis.
Conclusions
Postoperative endophthalmitis is one of the most devastating cataract surgery complications. Our results provide strong evidence of the utility of cefuroxime as prophylaxis of endophthalmitis after cataract surgery.
BarryP., GardnerS., SealD.ESCRS Endophthalmitis Study Group. Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery. J Cataract Refract Surg2009; 35: 1523–31.
2.
TabanM., BehrensA., NewcombR.L.Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol2005; 123: 613–20.
3.
KhanR.I., KennedyS., BarryP.Incidence of presumed postoperative endophthalmitis in Dublin for a 5-year period (1997-2001). J Cataract Refract Surg2005; 31: 1575–81.
4.
NagakiY., HayasakaS., KadoiC.Bacterial endophthalmitis after small-incision cataract surgery. effect of incision placement and intraocular lens type. J Cataract Refract Surg2003; 29: 20–6.
5.
CiullaT.A., StarrM.B., MasketS.Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology2002; 109: 13–24.
6.
Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol1995; 113: 1479–96.
7.
SealD.V., BarryP., GettinbyG.ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: case for a European multicenter study. J Cataract Refract Surg2006; 32: 396–406.
8.
MontanP.G., WejdeG., KoranyiG., RylanderM.Prophylactic intracameral cefuroxime: efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg2002; 28: 977–81.
9.
MontanP.G., WejdeG., SetterquistH., RylanderM., ZetterströmC.Prophylactic intracameral cefuroxime: evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg2002; 28: 982–7.
10.
BarryP., SealD.V., GettinbyG.the ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study. J Cataract Refract Surg2006; 32: 407–10.
11.
DelyferM.N., RougierM.B., LeoniS.Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg2011; 37: 271–8.
EspirituC.R., CaparasV.L., BolinaoJ.G.Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg2007; 33: 63–8.
14.
KowalskiR.P., RomanowskiE.G., MahF.S., YatesK.A., GordonY.J.Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol2005; 140: 497–504.
15.
StromanD.W., DajcsJ.J., CuppG.A., SchlechB.A.In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Surv Ophthalmol2005; 50(Suppl 1): S16–31.
16.
DeramoV.A., LaiJ.C., FastenbergD.M., UdellI.J.Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am J Ophthalmol2006; 142: 721–5.
17.
MillerD., FlynnP.M., ScottI.U., AlfonsoE.C., FlynnH.W.Jr.. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol2006; 124: 479–83.
18.
VillalobosP.A., ValleD.D.[The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis.]Arch Soc Esp Oftalmol2010; 85: 323–4.
19.
MyneniJ., DesaiS.P., JayamanneD.G.Reduction in postoperative endophthalmitis with intracameral cefuroxime. J Hosp Infect2013; 84: 326–8.
20.
FrilingE., LundströmM., SteneviU., MontanP.Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg2013; 39: 15–21.
21.
BarreauG., MounierM., MarinB., AdenisJ.P., RobertP.Y.Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. J Cataract Refract Surg2012; 38: 1370–5.
22.
García-SáenzM.C., Arias-PuenteA., Rodríguez-CaravacaG., Andrés AlbaY., Bañuelos BañuelosJ.[Endophthalmitis after cataract surgery: epidemiology, clinical features and antibiotic prophylaxis.]Arch Soc Esp Oftalmol2010; 85: 263–7.
23.
GualinoV., SanS., GuillotE.[Intracameral cefuroxime injections in prophylaxis of postoperative endophthalmitis after cataract surgery: implementation and results.]J Fr Ophtalmol2010; 33: 551–5.
24.
García-SáenzM.C., Arias-PuenteA., Rodríguez-CaravacaG., BañuelosJ.B.Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery: ten-year comparative study. J Cataract Refract Surg2010; 36: 203–7.
25.
SharifiE., PorcoT.C., NaseriA.Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology2009; 116: 1887–96.
26.
DíezM.R., De la RosaG., PascualR., GirónC., ArtetaM.[Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience.]Arch Soc Esp Oftalmol2009; 84: 85–9.
27.
CampagnaJ.D., BondM.C., SchabelmanE., HayesB.D.The use of cephalosporins in penicillin-allergic patients: a literature review. J Emerg Med2012; 42: 612–20.
